Last updated: February 15, 2023
Sponsor: Iran University of Medical Sciences
Overall Status: Active - Recruiting
Phase
N/A
Condition
Chronic Pain
Treatment
N/AClinical Study ID
NCT05214456
IR. IUMS.REC.1400.651
Ages 18-45 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Participants aged between 18 to 45 years.
- Moderate pain intensity (between 30 to 60) based on Numerical Pain Rating Scale (0means no pain and 100 is the most imaginable pain).
- Participants with trigger points in the quadratus lumborum and lumbar multifidusmuscles.
- The Participant's symptoms are provoked with passive accessory intervertebralmovements on at least one level of the lumbar spine vertebrae.
- Patients are able to read and write Persian.
Exclusion
Exclusion Criteria:
- Complications that affect the treatment process such as systemic diseases,neurological disorders, inflammatory conditions, infectious conditions, structural anddegenerative changes, metabolic bone diseases and bleeding disorders.
- History of lumbar surgery.
- Specific low back pain (Neurogenic low back pain, spinal stenosis, cauda equinasyndrome, spondylolisthesis, and Presence of any signs or symptoms of non-musculoskeletal pathology e.g. cancer, infection and fracture based on paraclinicalfindings)
- Inability to obtain prone lying.
- Pregnancy.
- Needle phobia.
- Long history of steroid use
Study Design
Total Participants: 56
Study Start date:
October 20, 2022
Estimated Completion Date:
December 30, 2023
Study Description
Connect with a study center
IRANums
Tehran,
Iran, Islamic Republic ofActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.